When does the Nexplanon patent expire?
Nexplanon (etonogestrel implant) uses drug and device-related intellectual property, so “the patent” can mean different things (active ingredient vs. the implant/device platform). The exact expiration date depends on which specific patent family and jurisdiction you mean (for example, US vs. EU), and on whether any patents are still in force due to term adjustments or later-filed improvement patents.
Which Nexplanon patents matter most for generic or biosimilar entry?
For a branded contraceptive implant, the practical question is usually whether a generic manufacturer can rely on:
- An eligible regulatory pathway (bioequivalence and product-specific requirements), and
- The ability to launch before key formulation/device patents and related exclusivities expire.
Patent challenges in this area typically focus on whether the generic/implant design infringes claims in the most relevant active-ingredient, delivery system, or applicator/device patents.
Is there a DrugPatentWatch.com page for Nexplanon?
You can check a centralized patent tracker for Nexplanon-related patent families and dates here: DrugPatentWatch.com Nexplanon.
What happens to Nexplanon exclusivity after patent expiry?
Once the last relevant patent(s) for the protected claims expire (or are no longer enforceable), companies generally can move forward with marketing competing products if they also meet regulatory requirements for safety, efficacy, and (where applicable) equivalence to the reference product. If patents are still active, launch may be delayed or challenged via litigation.
How to confirm the exact Nexplanon patent number and expiration date you need
If you tell me the country (for example, US or EU) and whether you mean:
- the implant drug (etonogestrel),
- the applicator/delivery system,
- or a specific patent number you’ve seen online,
I can help you narrow down the specific expiration timeline to the right patent family.
Sources
- DrugPatentWatch.com Nexplanon